Varigen™ Biosciences, Natural Products by Design™ is an NIH- and NSF-funded effort to harness naturally occurring microbial diversity to develop the next generation of natural product drugs through genomics and metagenomics.
BioForward recently welcomed Mohammed Soumaoro aboard as its membership experience and program coordinator. Soumaoro will support BioForward’s membership activities through improving membership experience and communications, supporting the purchasing consortium administration, internal project management, assisting with member events, and providing executive support to the CEO. “We are thrilled that Mohammed has joined our BioForward team,” CEO […]
This week, Promega Corporation announced the opening of the Kornberg Center, a new three-story 280,000-square-foot (over 85,000 square meters) research and development facility at its Fitchburg campus. Kornberg Center will support core product and technology development in life science research, cellular and molecular biology, genetic identity, clinical diagnostic and scientific applications, and training.
Located in the University of Wisconsin Research Park in Madison, Wisconsin, Object Pharma is developing new therapeutic drugs treating muscle hyperactivity. We also manufacture and sell all seven serotypes of botulinum toxin for use by accredited researchers worldwide.
At Gilson, we help life scientists at the bench achieve more productive research and verifiable data. And during the pandemic, we’ve helped support critical testing workflows and other COVID-related initiatives.
BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster representing more than 220 member organizations, is thrilled to announce the election of three new board members, effective January 1, 2021. Wisconsin has a uniquely diverse wealth of sectors that make up the Wisconsin biohealth region. BioForward serves all these sectors including research […]
By Janet WhiteBioForward Board MemberDirector of Strategic Portfolio Management, Promega With the rollercoaster of a year we’ve all experienced, the recently released Wisconsin Biohealth: Industry Landscape and Economic Impact Report has been a welcome bright spot highlighting the amazing successes of our region’s biohealth companies and organizations. Simply put, the biohealth industry is a leading […]
On April 16, 2020, Wisconsin Secretary-designee of the Department of Health Services, Andrea Palm, issued Emergency Order #28 at the direction of Governor Tony Evers. This new Order extends Wisconsin’s “Safer at Home” Order until 8:00 a.m. on May 26, 2020, or until a superseding order is issued, and modifies the original order. The original Safer at Home Order issued on March 25, Emergency Order #12, remains in effect until April 24, 2020.
BioForward is actively engaged with community partners, elected officials, state agencies and industry partners to meet the challenges of combating the coronavirus and demonstrating that Wisconsin can help lead the nation through this healthcare crisis. PPE Focus Eight Madison-area community providers serving people with developmental disabilities and seniors received much-needed PPE as they battle the […]
Read the full press release here Among people with cancer, people diagnosed with COVID-19 were more likely to be Black, have active cancer, have chronic conditions and live in zip codes with median household incomes below $30,000, according to a new study coauthored by two Advocate Aurora Health oncologists. A comparison between those with and without a […]
Read the full press release here Ongoing studies of immunity provided by available COVID-19 vaccines in the United States show that protection lasts at least six months, but many are asking if and when a booster vaccine might be necessary. Given the impact of immunization recommendations on public health strategy, attention to the issue is […]
Read the full press release here Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of patients with locally advanced cutaneous squamous cell carcinoma (cSCC) that is not curable […]
BioForward is reaching out to members to highlight their organizations through a new member profile feature to tell more of their stories. Atrility Medical agreed to be interviewed as a part of our efforts to heighten the awareness of our region and integrated health solutions approach. About Atrility Medical: A spin-off of UW-Madison technology, Atrility […]
Read the full press release here FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced that it has been awarded funding from the United States Department of Defense to conduct a safety and immunogenicity study of M2SR, the Company’s investigational, supra-seasonal, live, single-replication, intranasal influenza (flu) vaccine. This study […]
Read the full press release here Seven projects – from generating valuable products from the abundant non-food dairy residues that remain after milk is processed into food product, to amplifying UW–Madison doctoral trainees as the new generation of biotechnology industry leaders – have been chosen for funding through the Promoting Industry Collaboration Initiative. These projects […]
Read the full press release here SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also included participation by Fidelity Management & Research Company, Baillie Gifford and other new and current investors. The financing will support SHINE’s commercialization of its diagnostic […]
Read the full press release here The Advancing a Healthier Wisconsin Endowment (AHW), a statewide philanthropy based at the Medical College of Wisconsin (MCW), has announced the award of $6.5 million to 17 projects aimed at improving health and advancing health equity across Wisconsin. “At the Advancing a Healthier Wisconsin Endowment, we are working to create […]
BioForward is reaching out to members to highlight their organizations through a new member profile feature to tell more of their stories. FUJIFILM Cellular Dynamics, Inc. agreed to be interviewed as a part of our efforts to heighten the awareness of our region and integrated health solutions approach. About FUJIFILM Cellular Dynamics, Inc.: FUJIFILMCellular Dynamics, […]